Pharmacovigilance Regulation

This page is also available in:

Adopted on 28/03/2012
Reference
INT/639-EESC-2012-812
Opinion Type
Referral
Referral
COM(2012) 51 final - 2012/0023 (COD)
Official Journal
OJ C 181, 21.06.2012, p. 202
Plenary session number
479
-
Pharmaceuticals
Download — EESC opinion: Pharmacovigilance Regulation
docx
bg
cs
da
de
el
en
es
et
fi
fr
hu
it
lt
lv
mt
nl
pl
pt
ro
sk
sl
sv

Earlier EESC opinion:

For more information please contact the INT Section Secretariat

Recommended for you

  • Regulation repealing Regulation 1108/70 and Regulation (EC) 851/2006

    Opinion

    Practical informationAdministrator : Maja RADMAN, Assistant : Vicentzia NEAGUForeseen for the EESC Plenary meeting  26-27 October 2022 

  • Instant payments regulation

    Opinion

    European Economic and Social Committee's opinion on the Proposal for a Regulation of the European Parliament and of the Council amending Regulations (EU) No 260/2012 and (EU) 2021/1230 as…

  • Amendment to the InvestEU regulation

    Opinion

    Key pointsThe Committee has already set out its views on the Proposal for a regulation establishing the InvestEU programme[1], adopted on 17 October 2018 and on its revision[2], adopted on 15 July…

  • Revision of the Mercury Regulation

    Opinion

    Key pointsThe EESC:welcomes the Commission's proposal which targets the last intentional remaining uses of mercury in the EU, in order to safeguard the health and life of EU citizens and protect the…

  • Review of the securitisation regulation

    Opinion

    Key pointsThe EESC:calls to support the objectives of the European Commission's proposal;recommends that the review of reporting templates include standardised environmental, social and governance…